AI/ML Innovations Inc. Announces Settlement of Debt with ThreeD Capital Inc.
AI/ML Innovations Inc. has entered into a Debt Settlement and Security Agreement with ThreeD Capital Inc. for a debt of $47,460 related to services provided. The debt will be settled through the issuance of 949,200 common shares at a price of $0.05 per share. This transaction is subject to approval by the Canadian Securities Exchange (CSE) and the shares will be restricted for a four-month period.
AI/ML Innovations focuses on investments in artificial intelligence (AI) and machine learning (ML) within the digital health sector. Their strategic partnerships include a 95.2% stake in Health Gauge, 12.44% ownership in Tech2Heal (right to increase up to 22%), and a 70% stake in AI Rx Inc.
The company's shares trade on the Canadian Securities Exchange under the symbol AIML, on the OTCQB under AIMLF, and on the Frankfurt Stock Exchange under 42FB.
AI/ML Innovations Inc. ha stipulato un Accordo di Liquidazione del Debito e Garanzia con ThreeD Capital Inc. per un debito di 47.460 dollari relativo a servizi resi. Il debito sarà liquidato tramite l'emissione di 949.200 azioni ordinarie a un prezzo di 0,05 dollari per azione. Questa transazione è soggetta all'approvazione da parte della Canadian Securities Exchange (CSE) e le azioni saranno soggette a restrizioni per un periodo di quattro mesi.
AI/ML Innovations si concentra sugli investimenti nell'intelligenza artificiale (AI) e nell'apprendimento automatico (ML) nel settore della salute digitale. Le loro partnership strategiche includono una partecipazione del 95,2% in Health Gauge, una proprietà del 12,44% in Tech2Heal (con diritto di aumentare fino al 22%) e una partecipazione del 70% in AI Rx Inc.
Le azioni della società vengono negoziate sulla Canadian Securities Exchange con il simbolo AIML, sull'OTCQB con AIMLF, e sulla Borsa di Francoforte con 42FB.
AI/ML Innovations Inc. ha firmado un Acuerdo de Liquidación de Deuda y Garantía con ThreeD Capital Inc. por una deuda de 47.460 dólares relacionada con servicios prestados. La deuda se liquidará mediante la emisión de 949.200 acciones ordinarias a un precio de 0,05 dólares por acción. Esta transacción está sujeta a la aprobación de la Canadian Securities Exchange (CSE) y las acciones estarán restringidas por un período de cuatro meses.
AI/ML Innovations se centra en inversiones en inteligencia artificial (IA) y aprendizaje automático (ML) dentro del sector de salud digital. Sus asociaciones estratégicas incluyen una participación del 95,2% en Health Gauge, una propiedad del 12,44% en Tech2Heal (con derecho a aumentar hasta el 22%), y una participación del 70% en AI Rx Inc.
Las acciones de la compañía se negocian en la Canadian Securities Exchange bajo el símbolo AIML, en el OTCQB bajo AIMLF, y en la Bolsa de Frankfurt bajo 42FB.
AI/ML Innovations Inc.는 ThreeD Capital Inc.와 제공된 서비스와 관련된 47,460달러의 부채에 대한 부채 청산 및 담보 계약을 체결했습니다. 이 부채는 주당 0.05달러의 가격으로 949,200주를 발행하여 청산될 예정입니다. 이 거래는 캐나다 증권 거래소(CSE)의 승인을 받아야 하며, 주식은 4개월 동안 제한됩니다.
AI/ML Innovations는 디지털 헬스 분야에서 인공지능(AI) 및 머신 러닝(ML)에 대한 투자에 집중하고 있습니다. 그들의 전략적 파트너십에는 Health Gauge의 95.2% 지분, Tech2Heal의 12.44% 소유권(22%까지 증가할 권리 포함), AI Rx Inc.의 70% 지분이 포함됩니다.
회사의 주식은 캐나다 증권 거래소에서 AIML 기호로, OTCQB에서 AIMLF 기호로, 프랑크푸르트 증권 거래소에서 42FB 기호로 거래됩니다.
AI/ML Innovations Inc. a conclu un Accord de Règlement de Dettes et de Sécurité avec ThreeD Capital Inc. pour une dette de 47 460 dollars liée aux services fournis. La dette sera réglée par l'émission de 949 200 actions ordinaires à un prix de 0,05 dollar par action. Cette transaction est soumise à l'approbation de la Canadian Securities Exchange (CSE) et les actions seront restreintes pendant une période de quatre mois.
AI/ML Innovations se concentre sur les investissements en intelligence artificielle (IA) et en apprentissage automatique (ML) dans le secteur de la santé numérique. Leurs partenariats stratégiques incluent une participation de 95,2 % dans Health Gauge, une propriété de 12,44 % dans Tech2Heal (droit d'augmenter jusqu'à 22 %) et une participation de 70 % dans AI Rx Inc.
Les actions de la société se négocient sur la Canadian Securities Exchange sous le symbole AIML, sur le OTCQB sous AIMLF, et sur la Bourse de Francfort sous le symbole 42FB.
AI/ML Innovations Inc. hat einen Schuldenregulierungs- und Sicherungsvereinbarungen mit ThreeD Capital Inc. über eine Schuld von 47.460 US-Dollar im Zusammenhang mit erbrachten Dienstleistungen abgeschlossen. Die Schuld wird durch die Ausgabe von 949.200 Stammaktien zu einem Preis von 0,05 US-Dollar pro Aktie beglichen. Diese Transaktion unterliegt der Genehmigung durch die Canadian Securities Exchange (CSE) und die Aktien werden für einen Zeitraum von vier Monaten eingeschränkt.
AI/ML Innovations konzentriert sich auf Investitionen in künstliche Intelligenz (AI) und maschinelles Lernen (ML) im digitalen Gesundheitssektor. Zu ihren strategischen Partnerschaften gehören ein Anteil von 95,2% an Health Gauge, ein Anteil von 12,44% an Tech2Heal (mit dem Recht, bis zu 22% zu erhöhen), und ein Anteil von 70% an AI Rx Inc.
Die Aktien des Unternehmens werden an der Canadian Securities Exchange unter dem Symbol AIML, am OTCQB unter AIMLF, und an der Frankfurter Wertpapierbörse unter 42FB gehandelt.
- Debt of $47,460 will be converted into equity, improving the company's balance sheet.
- Issuing shares at $0.05 per share for debt conversion indicates a potential undervaluation of share price.
- Shareholder dilution due to issuance of 949,200 new shares.
VICTORIA, BC / ACCESSWIRE / August 15, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announced that it has entered into a Debt Settlement and Security Agreement with ThreeD Capital Inc. (the "Creditor") of Toronto, Ontario for payment of indebtedness owing to the Creditor in the aggregate total of
The Common Shares issued will be subject to a four-month hold period.
About AI/ML Innovations Inc. https://aiml-innovations.com/
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (
On behalf of the Board of Directors
Tim Daniels, Executive Chairman
For more information about AI/ML Innovations:
For detailed information please see AI/ML's website or the Company's filed documents at www.sedarplus.ca
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For AI/ML Innovations Investors
Certain statements made in this press release that are not based on historical information are forwardlooking statements that involve substantial known and unknown risks and uncertainties. This press release contains express or implied forward-looking statements relating to, among other things, AI/ML Innovations' expectations concerning management's plans, objectives, and strategies, including strategies for defending the Company's intellectual property. These statements are neither promises nor guarantees but are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. AI/ML Innovations Inc. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events, or circumstances or otherwise except as expressly required by applicable securities law. Further information regarding the uncertainties and risks can be found in the disclosure documents filed by AI/ML with the securities regulatory authorities, available at www.sedarplus.ca
SOURCE: AI/ML Innovations, Inc.
View the original press release on accesswire.com
FAQ
What is the debt settlement agreement between AI/ML Innovations and ThreeD Capital?
How many shares will AI/ML Innovations issue to settle its debt with ThreeD Capital?
What is the price per share for the debt conversion of AI/ML Innovations?
Is the debt settlement between AI/ML Innovations and ThreeD Capital subject to any approvals?
What is the stock symbol of AI/ML Innovations on the OTCQB market?
